Sensex Slips Over 100 Points, Nifty Trades At 11,430; Sun Pharma, SBI Fall 2%
- Top laggards in the Sensex pack in opening trade today were Induslnd Bank (-0.05%), Larsen & Tourbo (-0.10%), Maruti (-0.17%), Reliance (-0.24%) and Sun Pharma (-0.81%). Main losers on the NSE index in the morning session were SBIN, Grasim, Axis Bank, Coal India and Bajaj Finance.
- According to market observers, heavy selling pressure was witnessed in banking, oil and gas and metal stocks.
- Asia stock markets skidded on Friday amid heightened global trade tensions, while currency markets were whipsawed by a searing selloff in Russia's rouble after the United States slapped on new sanctions, and as economic worries sent the Turkish lira tumbling.
- Hong Kong's Hang Seng was down 0.40 per cent, Japan's Nikkei shed 0.53 per cent and Shanghai Composite Index fell 0.15 per cent.  Â
- Stocks of State Bank of India (SBI), GAIL, United Bank are in focus toady as these companies are set to release their June quarter results later in the day.Â
- Jet Airways on Thursday said that its Board has deferred the consideration of unedited financial results for the first quarter of the current financial year 2018-19.
- Globally, oil prices also fell on Friday, pulled down by concerns that the escalating trade dispute between the United States and China would stall economic growth and fuel demand.
- Major gainers in the 30-share Sensex pack were Tata Motors (+1.50%), Vedanta (+1.21%), Hindustan Unilever (+0.65), NTPC (0.37%) and HeroMotoCorp (+0.33%). Eicher Motors, Yes Bank, UPL, Bharti Airtel and Titan were leading the pack of Nifty gainers.
- Meanwhile, domestic institutional investors (DIIs) sold shares worth a net Rs 85.39 crore, while foreign portfolio investors (FPIs) bought shares worth Rs 370.68 crore on Thursday, provisional data showed.  Â
- On Thursday, the domestic benchmark indices extended their record-breaking run with BSE benchmark index Sensex breaching the 38,000 level for the first time ever. The Sensex ended at 38,024 while the NSE Nifty settled at 11,470, both record closing highs. (With agencies inputs)
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.